These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

561 related articles for article (PubMed ID: 33234007)

  • 1. Responsiveness of Inhaled Epoprostenol in Respiratory Failure due to COVID-19.
    Sonti R; Pike CW; Cobb N
    J Intensive Care Med; 2021 Mar; 36(3):327-333. PubMed ID: 33234007
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting Impact of Prone Position on Oxygenation in Mechanically Ventilated Patients with COVID-19.
    Bell J; William Pike C; Kreisel C; Sonti R; Cobb N
    J Intensive Care Med; 2022 Jul; 37(7):883-889. PubMed ID: 35195460
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhaled pulmonary vasodilators are not associated with improved gas exchange in mechanically ventilated patients with COVID-19: A retrospective cohort study.
    Lubinsky AS; Brosnahan SB; Lehr A; Elnadoury O; Hagedorn J; Garimella B; Bender MT; Amoroso N; Artigas A; Bos LDJ; Kaufman D
    J Crit Care; 2022 Jun; 69():153990. PubMed ID: 35180636
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nitric oxide versus epoprostenol for refractory hypoxemia in Covid-19.
    Poonam PBH; Koscik R; Nguyen T; Rikhi S; Lin HM
    PLoS One; 2022; 17(6):e0270646. PubMed ID: 35759496
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Evaluation of Continuous Inhaled Epoprostenol in the Treatment of Acute Respiratory Distress Syndrome, Including Patients With SARS-CoV-2 Infection.
    Niss HL; Mohamed A; Berry TP; Saettele TM; Haines MM; Thomas EL
    Ann Pharmacother; 2022 Oct; 56(10):1093-1099. PubMed ID: 35021923
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Limitations of the ARDS criteria during high-flow oxygen or non-invasive ventilation: evidence from critically ill COVID-19 patients.
    Hultström M; Hellkvist O; Covaciu L; Fredén F; Frithiof R; Lipcsey M; Perchiazzi G; Pellegrini M
    Crit Care; 2022 Mar; 26(1):55. PubMed ID: 35255949
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Comparison of Inhaled Epoprostenol in Patients With Acute Respiratory Distress Syndrome and COVID-19-Associated Acute Respiratory Distress Syndrome.
    Robinson J; Santarelli A; Wilks N; Latu L; Charran O; Lalitsasivimol D; Dietrich T; Ashurst J
    Cureus; 2022 Aug; 14(8):e28274. PubMed ID: 36158384
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prone positioning in mechanically ventilated patients with severe acute respiratory distress syndrome and coronavirus disease 2019.
    Gleissman H; Forsgren A; Andersson E; Lindqvist E; Lipka Falck A; Cronhjort M; Dahlberg M; Günther M
    Acta Anaesthesiol Scand; 2021 Mar; 65(3):360-363. PubMed ID: 33165936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Inhaled epoprostenol vs inhaled nitric oxide for refractory hypoxemia in critically ill patients.
    Torbic H; Szumita PM; Anger KE; Nuccio P; LaGambina S; Weinhouse G
    J Crit Care; 2013 Oct; 28(5):844-8. PubMed ID: 23683572
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhaled Epoprostenol Through Noninvasive Routes of Ventilator Support Systems.
    Ammar MA; Sasidhar M; Lam SW
    Ann Pharmacother; 2018 Dec; 52(12):1173-1181. PubMed ID: 29890848
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and Economic Impact of Formulary Conversion From Inhaled Flolan to Inhaled Veletri for Refractory Hypoxemia in Critically Ill Patients.
    Torbic H; Szumita PM; Anger KE; Nuccio P; Lagambina S; Weinhouse G
    Ann Pharmacother; 2016 Feb; 50(2):106-12. PubMed ID: 26668204
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of inhaled prostacyclin in treating acute respiratory distress syndrome.
    Searcy RJ; Morales JR; Ferreira JA; Johnson DW
    Ther Adv Respir Dis; 2015 Dec; 9(6):302-12. PubMed ID: 26294418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of 2 different inhaled epoprostenol dosing strategies for acute respiratory distress syndrome in critically ill adults: Weight-based vs fixed-dose administration.
    Buckley MS; Mendez A; Radosevich JJ; Agarwal SK; MacLaren R
    Am J Health Syst Pharm; 2023 Feb; 80(Suppl 1):S11-S22. PubMed ID: 35877207
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Response to the first awake prone positioning relates with intubation rate in SARS-CoV-2 patients suffering from acute respiratory failure with moderate to severe hypoxaemia: a retrospective study.
    Lupieri E; Boffi A; Ltaief Z; Schneider A; Abed-Maillard S; Chiche JD; Oddo M; Piquilloud L
    Swiss Med Wkly; 2022 Aug; 152():w30212. PubMed ID: 36102065
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of prone positioning on oxygenation and static respiratory system compliance in COVID-19 ARDS vs. non-COVID ARDS.
    Park J; Lee HY; Lee J; Lee SM
    Respir Res; 2021 Aug; 22(1):220. PubMed ID: 34362368
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prone positioning for mechanically ventilated patients with coronavirus disease 2019: the experience of an Irish regional hospital intensive care unit.
    Di Mascio N; Clarke S; de Loughry G; Altaf W
    Ir J Med Sci; 2023 Jun; 192(3):1329-1334. PubMed ID: 35819744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Magnitude and time to peak oxygenation effect of prone positioning in ventilated adults with COVID-19 related acute hypoxemic respiratory failure.
    Rollinson TC; McDonald LA; Rose J; Eastwood G; Costa-Pinto R; Modra L; Maeda A; Bacolas Z; Anstey J; Bates S; Bradley S; Dumbrell J; French C; Ghosh A; Haines K; Haydon T; Hodgson C; Holmes J; Leggett N; McGain F; Moore C; Nelson K; Presneill J; Rotherham H; Said S; Young M; Zhao P; Udy A; Chaba A; Bellomo R; Neto AS
    Acta Anaesthesiol Scand; 2024 Mar; 68(3):361-371. PubMed ID: 37944557
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Severity of Hypoxemia and Other Factors That Influence the Response to Aerosolized Prostacyclin in ARDS.
    Kallet RH; Burns G; Zhuo H; Ho K; Phillips JS; Pangilinan LP; Yip V; Gomez A; Lipnick MS
    Respir Care; 2017 Aug; 62(8):1014-1022. PubMed ID: 28559468
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characteristics and risk factors associated with mortality during the first cycle of prone secondary to ARDS due to SARS-CoV-2 pneumonia.
    Gonzalez C; Musso G; Louzan JR; Dominguez JM; Gomez C; Appendino G; Abaca A; Clemente L; Latasa D; Manago M; Lovesio C; Estenssoro E
    Med Intensiva (Engl Ed); 2024 Mar; 48(3):133-141. PubMed ID: 37714730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Noninferiority of Inhaled Epoprostenol to Inhaled Nitric Oxide for the Treatment of ARDS.
    Ammar MA; Bauer SR; Bass SN; Sasidhar M; Mullin R; Lam SW
    Ann Pharmacother; 2015 Oct; 49(10):1105-12. PubMed ID: 26187741
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 29.